Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 1857-1864

  Kaatz, Glenn W ^a,b   McAleese, Fionnuala ^c   Seo, Susan M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BIOCIDE; CARRIER PROTEIN; CIPROFLOXACIN; DIVALENT CATION; ETHIDIUM BROMIDE; MONOVALENT CATION; MOXIFLOXACIN; NORFLOXACIN; PROTEIN MATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; DNA MICROARRAY; DRUG SENSITIVITY; GENE OVEREXPRESSION; MEPA GENE; MEPB GENE; MEPR GENE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; SEQUENCE HOMOLOGY; STAPHYLOCOCCUS AUREUS;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CLOSTRIDIUM DIFFICILE; COMPUTATIONAL BIOLOGY; CULTURE MEDIA; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, MDR; INDICATORS AND REAGENTS; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; REPRESSOR PROTEINS; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION, GENETIC;

EID: 18244388696     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.1857-1864.2005     Document Type: Article

References (38)

1. Bateman, B. T., N. P. Donegan, T. M. Jarry, M. Palma, and A. L. Cheung. 2001. Evaluation of a tetracydine-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect. Immun. 69:7851-7857.
2. Beenken, K. E., P. M. Dunman, F. McAleese, D. Macapagal, E. Murphy, S. J. Projan, J. S. Blevins, and M. S. Smeltzer. 2004. Global gene expression in Staphytococcus aureus biofilms. J. Bacteriol. 186:4665-4684.
3. Bolotin, A., P. Wincker, S. Mauger, O. Jaillon, K. Malarme, J. Weissenbach, S. Dusko Erlich, and A. Sorokin. 2001. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 11:731-753.
4. Borgess-Walmsley, M. I., K. S. McKeegan, and A. R. Walmsley. 2003. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376:313-338.
5. Burse, A., H. Weingart, and M. S. Ullrich. 2004. NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria. Appl. Environ. Microbiol. 70:693-703.
6. 5a. Diener, A. C., R. A. Gaxiola, and G. R. Fink. 2001. Arabidopsis ALF5, a multidrug efflux transporter gene family member, confers resistance to toxins. Plant Cell 13:1625-1637.
7. Dridi, L., J. Tankovic, and J.-C. Petit. 2004. CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family. Microb. Drug Resist. 10:191-196.
8. Dunman, P. M., W. Mounts, F. McAleese, F. Immermann, D. Macapagal, E. Marsilio, L. McDougal, F. C. Tenover, P. A. Bradford, P. J. Petersen, S. J. Projan, and E. Murphy. 2004. Uses of Staphylococcus aureus GeneChips in genotyping and genetic composition analysis. J. Clin. Microbiol. 42:4275-4283.
9. Farrow, K. A., D. Lyras, and J. I. Rood. 2001. Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile. Microbiology 147:2717-2728.
10. Foster, T. J. 1998. Molecular genetic analysis of staphylococcal virulence. Methods Microbiol. 27:433-454.
11. Glaser, P., L. Frangeul, C. Buchrieser, C. Rusniok, A. Amend, F. Baquero, P. Berche, H. Bloecker, P. Brandt, T. Chakraborty, A. Charbit, F. Chetouani, E. Couvé, A. de Daruvar, P. Dehoux, E. Domann, G. Dominguez-Bernal, E. Duchard, L. Durant, O. Dussurget, K.-D. Entian, H. Fsihi, F. Garcia-Del Portillo, P. Garrido, L. Gautier, W. Goebel, N. Gómez-López, T. Hain, J. Hauf, D. Jackson, L.-M. Jones, U. Kaerst, J. Kreft, M. Kuhn, F. Kunst, G. Kurapkat, E. Madueño, A. Maitournam, J. Mata Vicente, E. Ng, H. Nedjari, G. Nordsiek, S. Novella, B. de Pablos, J.-C. Pérez-Diaz, R. Purcell, B. Remmel, M. Rose, T. Schlueter, N. Simoes, A. Tierrez, J.-A. Vázquez-Boland, H. Voss, J. Wehland, and P. Cossart. 2001. Comparative genomics of Listeria species. Science 294:849-852.
12. He, G.-X., T. Kuroda, T. Mima, Y. Morita, T. Mizushima, and T. Tsuchiya. 2004. An H+-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. 3. Bacteriol. 186:262-265.
13. Huang, J., P. W. O'Toole, W. Shen, H. Amrine-Madsen, X. Jiang, N. Lobo, L. M. Palmer, L. Voekler, F. Fan, M. N. Gwynn, and D. McDevitt. 2004. Novel chromosomally encoded multidrug efflux transporter MdcA in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:909-917.
14. Huda, M. N., J. Chen, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Gene cloning and characterization of VcrM, a Na+-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol. Immunol. 47:419-427.
15. Huda, M. N., Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2001. Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol. Lett. 203:235-239.
16. Kaatz, G. W., V. V. Moudgal, and S. M. Seo. 2002. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J. Antimicrob. Chemother. 50:833-838.
17. Kaatz, G. W., S. M. Seo, L. O'Brien, M. Wahiduzzaman, and T. J. Foster. 2000. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob. Agents Chemother. 44: 1404-1406.
18. Kemp, E. H., R. L. Sammons, A. Moir, D. Sun, and P. Setlow. 1991. Analysis of transcriptional control of the gerD spore germination gene of Bacillus subtilis 168. J. Bacteriol. 173:4646-4652.
19. Kim, R. B. 2002. Transporters and xenobiotic disposition. Toxicology 181-182:291-297.
20. Kreiswirth, B. N., M. S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by prophage. Nature 305:709-712.
21. Lewin, B. 1994. Control by RNA structure: termination and antitermination, p. 460-462. In B. Lewin (ed.), Genes V. Oxford University Press. Inc., New York, N.Y.
22. Manna, A. C., M. G. Bayer, and A. L. Cheung. 1998. Transcriptional analysis of different promoters in the sar locus of Staphylococcus aureus. J. Bacteriol. 180:3828-3836.
23. Markham, P. N., and A. A. Neyfakh. 1996. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:2673-2674.
24. Mitchell, B. A., I. T. Paulsen, M. H. Brown, and R. A. Skurray. 1999. Bioenergetics of the staphylococcal multidrug export protein QacA. J. Biol. Chem. 274:3541-3548.
25. Miyamae, S., O. Ueda, F. Yoshimura, J. Hwang, Y. Tanaka, and H. Nikaido. 2001. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45: 3341-3346.
26. +-driven multidrug efflux pump. J. Bacteriol. 182:6694-6697.
27. Morita, Y., K. Kodama, S. Shiota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42:1778-1782.
28. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. NCCLS publication no. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
29. Novick, R. 1967. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
30. Paulsen, I. T., M. H. Brown, T. G. Littlejohn, B. A. Mitchell, and R. A. Skurray. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. USA 93:3630-3635.
31. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
32. Price, C. T. D., G. W. Kaatz, and J. E. Gustafson. 2002. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus. Int. J. Antimicrob. Agents 20:206-213.
33. Putman, M., H. W. van Veen, and W. N. Konings. 2000, Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:672-693.
34. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
35. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
36. Ubukata, K., N. Itoh-Yamashita, and M. Konno. 1989. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33:1535-1539.
37. Van Bambeke, F., E. Balzi, and P. M. Tulkens. 2000. Antibiotic efflux pumps. Biochem. Pharmacol. 60:457-470.
38. Xu, X. J., Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzas Rd. Microbiol. Immunol. 47:937-943.